Lv3
258 积分 2021-08-12 加入
Therapy with oncolytic viruses: progress and challenges
8天前
已完结
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
9天前
已完结
Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
2个月前
已完结
CD4+ T cell memory
3个月前
已完结
Two parallel worlds of memory T cells
3个月前
已完结
Gene-engineered T cells for cancer therapy
4个月前
已完结
Metabolic waypoints during T cell differentiation
6个月前
已完结
Optimizing the manufacturing and antitumour response of CAR T therapy
6个月前
已完结
Release Assays and Potency Assays for CAR T-Cell Interventions
6个月前
已完结
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
6个月前
已完结
皖公网安备34019202002308
